Renasant Bank Amgen Inc Transaction History

Renasant Bank

$138 Million
Q1 2024

A detailed history of Renasant Bank transactions in Amgen Inc stock. As of the latest transaction made, Renasant Bank holds 1,618 shares of AMGN stock, worth $503,003. This represents 0.33% of its overall portfolio holdings.

Number of Shares

1,618

Previous 1,644 1.58%

Holding current value

$503,003

Previous $473,000 2.75%

% of portfolio

0.33%

Previous 0.38%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $6,990 - $8,438	-26 Reduced 1.58%	1,618 $460,000
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $94,864 - $107,018	-371 Reduced 18.41%	1,644 $473,000
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $2,405 - $2,986	11 Added 0.55%	2,015 $541,000
Q2 2023 Aug 01, 2023	SELL	$214.27 - $253.37 $31,497 - $37,245	-147 Reduced 6.83%	2,004 $444,000
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $41,319 - $50,361	183 Added 9.3%	2,151 $520,000

Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $113,369 - $144,049	-495 Reduced 20.1%	1,968 $516,000
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $133,104 - $150,117	593 Added 31.71%	2,463 $555,000
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $84,209 - $93,710	-365 Reduced 16.33%	1,870 $455,000
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $33,329 - $36,870	152 Added 7.3%	2,235 $540,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $88,103 - $100,826	-443 Reduced 17.54%	2,083 $469,000
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $379,326 - $444,426	-1,787 Reduced 41.43%	2,526 $537,000
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $11,679 - $12,957	50 Added 1.17%	4,313 $1.05 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $199,275 - $232,222	-898 Reduced 17.4%	4,263 $1.06 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.12 Million - $1.33 Million	5,161 New	5,161 $1.19 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

News

Stay updated on Renasant Bank with notifications on news.

Account